These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Comparative clinical study of the oral hypoglycemic agent HB 419 or glibenclamide]. Giraudo JR. Rev Clin Esp; 1972 Nov 15; 127(3):815-20. PubMed ID: 4631447 [No Abstract] [Full Text] [Related]
4. [Glibenclamide-phenformin combination in the treatment of diabetes in adults]. Pittera A, Ruvolo F, Di Blasi F. Clin Ter; 1975 Aug 15; 74(3):231-58. PubMed ID: 819201 [No Abstract] [Full Text] [Related]
7. [Practical viewpoints on the treatment of diabetes with glibenclamide]. Wadman B, Werner I. Lakartidningen; 1972 Sep 06; 69(37):4084-6. PubMed ID: 4627109 [No Abstract] [Full Text] [Related]
10. Longterm clinical study with glibenclamide. Solanki SV, Yajnik VH, Shah SS, Shah DP. J Assoc Physicians India; 1973 Jan 06; 21(1):1-9. PubMed ID: 4209374 [No Abstract] [Full Text] [Related]
11. Treatment with glibenclamide in maturity-onset diabetes mellitus. Persson I, Madsen SN. Geriatrics; 1971 May 06; 26(5):182-3 passim. PubMed ID: 4997365 [No Abstract] [Full Text] [Related]
12. [Treatment of overweight diabetics with a combination of glibenclamide and phenformin]. Palmieri G, Alkabes M. Clin Ter; 1977 Jun 30; 81(6):537-46. PubMed ID: 407046 [No Abstract] [Full Text] [Related]
13. [Glibenclamide in type II diabetes as compared with placebo]. Breier C, Lisch HJ, Drexel H, Sailer S. Wien Klin Wochenschr; 1983 Mar 18; 95(6):200-3. PubMed ID: 6410589 [Abstract] [Full Text] [Related]
14. [Glibenclamide and diabetes mellitus. 1. Year's clinical experience]. Contreras AR, Gabrielli S, Baigorria L. Prensa Med Argent; 1972 May 12; 59(15):581-3. PubMed ID: 4626172 [No Abstract] [Full Text] [Related]
15. [Controlled clinical study of a new oral antidiabetic formed by a glibenclamide-phenformin association]. Torri A, Zanni A. Clin Ter; 1974 Aug 15; 70(3):236-57. PubMed ID: 4214456 [No Abstract] [Full Text] [Related]
16. [Preliminary clinical experiences and problems of long-term therapy of diabetes mellitus using 2nd generation sulfonylurea derivatives (glibenclamide)]. Schilling I, Bruns W, Haller H, Mehnert E, Mohnike A, Jutzi E, Schliack V, Schulze J. Z Gesamte Inn Med; 1973 May 15; 28(10):Suppl 10:149-5. PubMed ID: 4200337 [No Abstract] [Full Text] [Related]
17. [Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin]. Giangrandi E, Scaroina F, Tommasini-Degna C. Minerva Med; 1975 Mar 14; 66(19):940-5. PubMed ID: 804684 [No Abstract] [Full Text] [Related]
18. [Insulin plus sulphonyl-urea compounds in the treatment of diabetes mellitus of the maturity-onset type (author's transl)]. Traumann KJ, Hösl W, Grom E, Wittemann G. Dtsch Med Wochenschr; 1982 Feb 05; 107(5):180-4. PubMed ID: 6799267 [No Abstract] [Full Text] [Related]
19. [Behavior of blood sugar and insulin in diabetics at the suspension of glibenclamide therapy]. Pitucco G, Caputo V, Santucci A, Daniele E, De Mattia G, De Angelis A. Clin Ter; 1978 Jun 30; 85(6):550-8. PubMed ID: 97042 [No Abstract] [Full Text] [Related]